(Q47272020)

English

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

7

0 references

author name string

Shi-Ming Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Chun-Jung Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Chao-Wei Hsu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Dar-In Tai

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

I-Shyan Sheen

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Deng-Yn Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

100

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

376-382

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Radiofrequency ablation of the liver: current status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Cytologic changes in hepatocellular carcinoma after percutaneous acetic acid injection. Correlation with helical computed tomography findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

21 January 2018

Hepatocellular carcinoma: an Asian perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/14716774

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47272020&oldid=2149662044"